HLB Life Science CO.,LTD.
Develops anti-cancer drugs and distributes IVD medical devices and lab supplies internationally.
067630 | KO
Overview
Corporate Details
- ISIN(s):
- KR7067630004
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 동탄첨단산업1로 51-9 8층(영천동,엠타워지식산업센터), 화성시
- Website:
- https://www.hlb-lsmc.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
HLB Life Science Co., Ltd. is a specialized pharmaceutical and biotechnology firm operating with a dual focus. The company is dedicated to the development of innovative and differentiated anti-cancer medications as part of the broader HLB Group's global oncology strategy. Concurrently, its Medicare business develops, manufactures, and distributes a range of products including in-vitro diagnostic (IVD) medical devices, quasi-drugs, research reagents, and laboratory supplies. The company serves both domestic and international markets, providing healthcare solutions that span from diagnostics to therapeutics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-13 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 2.0 MB | ||
| 2025-08-01 00:00 |
M&A Activity
[기재정정]주요사항보고서(회사합병결정)
|
Korean | 56.6 KB | ||
| 2025-08-01 00:00 |
M&A Activity
기타주요경영사항 (회사 합병결정 철회)
|
Korean | 4.1 KB | ||
| 2025-07-10 00:00 |
Post-Annual General Meeting Information
임시주주총회결과
|
Korean | 7.1 KB | ||
| 2025-06-19 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 141.4 KB | ||
| 2025-06-19 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 110.7 KB | ||
| 2025-05-29 00:00 |
Capital/Financing Update
전환가액의조정 (제13회차)
|
Korean | 10.7 KB | ||
| 2025-05-19 00:00 |
M&A Activity
[기재정정]주요사항보고서(회사합병결정)
|
Korean | 81.4 KB | ||
| 2025-05-19 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
|
Korean | 12.5 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.9 MB | ||
| 2025-04-15 00:00 |
Delisting Announcement
기타시장안내 (에이치엘비생명과학 9WR 신주인수권 행사기간 만료 및 상장폐지 예고)
|
Korean | 3.4 KB | ||
| 2025-04-10 00:00 |
Related Party Transaction
임원ㆍ주요주주특정증권등거래계획철회보고서
|
Korean | 16.1 KB | ||
| 2025-04-10 00:00 |
Share Issue/Capital Change
전환가액의조정 (제14회차)
|
Korean | 10.3 KB | ||
| 2025-04-08 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 83.0 KB | ||
| 2025-04-07 00:00 |
Capital/Financing Update
전환가액의조정 (제11회차)
|
Korean | 12.0 KB |
Automate Your Workflow. Get a real-time feed of all HLB Life Science CO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HLB Life Science CO.,LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HLB Life Science CO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
